Space Peptides

Space Peptides combines big data on drug structures with artificial intelligence (AI) to focus on building a one-stop AI-CRDMO service platform for peptides, peptidomimetics, and peptide-drug conjugates (PDCs), covering everything from new drug discovery (CRO) to industrial production (CMO/CDMO). Space Peptides adopts a co-development model with pharmaceutical companies, providing services such as AI-based drug molecule design and synthesis, preclinical animal experiment validation, delivery of patentable preclinical candidate compounds (PCC), innovative drug clinical trial applications, and raw material production and supply for all stages including clinical research and large-scale commercialization after drug market approval.